Following a negative FDA advisory committee vote earlier this year, the other shoe has dropped for Lundbeck and Otsuka Pharmaceutical’s post-traumatic stress disorder (PTSD) hopeful. The FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results